The Monthly Cycle of Hypoglycemia An Observational Claims-based Study of Emergency Room Visits, Hospital Admissions, and Costs in a Commercially Insured Population

被引:63
|
作者
Basu, Sanjay [1 ,2 ,3 ]
Berkowitz, Seth A. [4 ,5 ,6 ]
Seligman, Hilary [7 ,8 ,9 ]
机构
[1] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Ctr Populat Hlth Sci, Palo Alto, CA 94304 USA
[3] Harvard Med Sch, Ctr Primary Care, Boston, MA USA
[4] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
[6] Harvard Med Sch, Dept Med, Boston, MA USA
[7] San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94110 USA
[8] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[9] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
hypoglycemia; type II diabetes; social determinants of health; food insecurity; emergency room visits; hospitalization; FOOD INSECURITY; DIABETES-MELLITUS; SOUTH SIDE; HEALTH; RISK; ASSOCIATION; CARE; MEDICARE; DISEASE; ADULTS;
D O I
10.1097/MLR.0000000000000728
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Multipayer initiatives have sought to address social determinants of health, such as food insecurity, by linking primary care patients to social services. It remains unclear whether such social determinants contribute to avoidable short-term health care costs. Objectives: We sought to quantify costs and mitigating factors for the increased risk of hypoglycemia at the end of each month among low-income Americans, a phenomenon related to exhaustion of food budgets. Research Design: We used claims data on 595,770 commercially insured American adults aged 19 through 64 years old from 2004 through 2015 to estimate the risks and costs of emergency room visits and inpatient hospitalizations for hypoglycemia during the last week of each month versus prior weeks. Results: Although persons with household incomes greater than the national median did not experience a monthly cycle of hypoglycemia, those with incomes less than the national median had an odds ratio of 1.07 (95% confidence interval, 1.02-1.12; P = 0.005) for emergency room visits or inpatient hospitalizations for hypoglycemia during the last week of each month, compared with earlier weeks. The risk of end-of-the-month hypoglycemia was mitigated to statistical insignificance during a period of increased federal nutrition program benefits from 2009 through 2013. Eliminating the monthly cycle of hypoglycemia among commercially insured nonelderly adults would be expected to avert $54.1 million per year (95% confidence interval, $0.8-$204.0) in emergency department and inpatient hospitalization costs. Conclusions: Addressing the end-of-the-month increase in hypoglycemia risk among lower-income populations may avert substantial costs from emergency department visits and inpatient hospitalizations.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 50 条
  • [1] Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured population
    Eisenberg, Debra F.
    Daniel, Gregory W.
    Jones, Judith K.
    Goehring, Earl L., Jr.
    Wahl, Peter M.
    Winters, Peter
    Levin, Jay
    Bohn, Rhonda L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (07) : 760 - 764
  • [2] Using a Claims-Based Framework to Identify Severe Maternal Morbidities in a Commercially Insured US Population
    Chaisson, Christine E.
    Ameli, Omid
    Paterson, Victoria J.
    Weiseth, Amber
    Genen, Linda
    Thayer, Sarah
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2021, 35 (03) : 237 - 246
  • [3] Replication of a Claims-based Algorithm to Estimate Multiple Sclerosis Disease Severity in a Commercially Insured Population
    Toliver, Joshua
    Barner, Jamie C.
    Lawson, Kenneth
    Sonawane, Kalyani
    Rascati, Karen
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [4] Estimation of Gestational Age at Birth Using Claims-Based Algorithms in a Commercially Insured US Population
    Wallace, Anna E.
    Lee, Brian K.
    Selvam, Nandini
    Tabb, Loni
    Yudell, Michael
    Turchi, Renee
    Newschaffer, Craig J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 299 - 300
  • [5] Validation of Claims-Based Diagnostic Codes for Severe Hypoglycemic Events (SHEs) in a Commercially-Insured Population
    Eisenberg, Debra F.
    Daniel, Gregory W.
    Subramanian, Usha
    Breen, Tracy
    Bohn, Rhonda L.
    Wahl, Peter M.
    Herman, William H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S74 - S74
  • [6] Validation of Claims-Based Diagnostic and Procedure Codes for Serious Adverse Events in a Commercially-Insured Population
    Wahl, Peter M.
    Rodgers, Keith
    Schneeweiss, Sebastian
    Gage, Brian F.
    Short, Louise J.
    Bohn, Rhonda L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S67 - S67
  • [7] Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population
    Wahl, Peter M.
    Terrell, Deirdra R.
    George, James N.
    Rodgers, J. Keith
    Uhl, Lynn
    Cataland, Spero
    Bohn, Rhonda L.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) : 1203 - 1209
  • [8] Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
    Kern, David M.
    Davis, Jill
    Williams, Setareh A.
    Tunceli, Ozgur
    Wu, Bingcao
    Hollis, Sally
    Strange, Charlie
    Trudo, Frank
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1417 - 1425
  • [9] Validation of a Claims-Based Diagnostic Code for Stevens-Johnson Syndrome (SJS']JS) in a Commercially-Insured Population
    Daniel, Gregory W.
    Eisenberg, Debra F.
    Jones, Judith K.
    Goehring, Earl L.
    Winters, Peter
    Levin, Jay
    Wahl, Peter M.
    Bohn, Rhonda L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S195 - S196
  • [10] Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
    Wahl, Peter M.
    Rodgers, Keith
    Schneeweiss, Sebastian
    Gage, Brian F.
    Butler, Javed
    Wilmer, Charles
    Nash, Marshall
    Esper, Gregory
    Gitlin, Norman
    Osborn, Neal
    Short, Louise J.
    Bohn, Rhonda L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (06) : 596 - 603